Align Technology, Inc. $ALGN Stock: New Mexico Educational Retirement Board Raises Holdings

Posted by Francis Steltz on Nov 12th, 2026

New Mexico Educational Retirement Board boosted its position in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 1,650.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,630 shares of the medical equipment provider’s stock after buying an additional 55,280 shares during the period. New Mexico Educational Retirement Board’s holdings in Align Technology were worth $7,801,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Assenagon Asset Management S.A. raised its stake in Align Technology by 638.7% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider’s stock worth $629,469,000 after buying an additional 4,031,284 shares during the period. BlackRock Inc. acquired a new stake in Align Technology in the second quarter valued at approximately $745,370,000. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA grew its stake in Align Technology by 3,162.7% in the third quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider’s stock valued at $278,342,000 after acquiring an additional 2,033,451 shares during the period. Vontobel Holding Ltd. increased its holdings in shares of Align Technology by 69,628.9% during the third quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider’s stock valued at $183,335,000 after acquiring an additional 1,383,526 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its position in shares of Align Technology by 4.9% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,054,633 shares of the medical equipment provider’s stock worth $180,796,000 after purchasing an additional 49,220 shares during the period. 88.43% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on ALGN shares. Robert W. Baird downgraded shares of Align Technology from an “outperform” rating to a “neutral” rating and reduced their price target for the company from $218.00 to $162.00 in a research report on Thursday, October 15th. Weiss Ratings raised shares of Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. Piper Sandler dropped their price objective on shares of Align Technology from $235.00 to $205.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 21st. Zacks Research cut shares of Align Technology from a “hold” rating to a “strong sell” rating in a report on Thursday, October 15th. Finally, Raymond James Financial restated a “buy” rating on shares of Align Technology in a report on Monday, October 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Align Technology presently has an average rating of “Moderate Buy” and an average target price of $193.08.

View Our Latest Analysis on ALGN

Align Technology Stock Down 1.3%

Shares of ALGN stock opened at $172.08 on Thursday. The firm has a market cap of $12.13 billion, a P/E ratio of 25.05, a PEG ratio of 2.26 and a beta of 1.74. The company has a 50 day moving average of $151.34 and a 200-day moving average of $168.56. Align Technology, Inc. has a 12-month low of $130.23 and a 12-month high of $200.43.

Align Technology (NASDAQ:ALGN – Get Free Report) last released its quarterly earnings data on Wednesday, October 28th. The medical equipment provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.77 by $0.03. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. Align Technology’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same period last year, the firm earned $2.61 EPS. As a group, equities analysts expect that Align Technology, Inc. will post 9.21 EPS for the current year.

Align Technology Company Profile

(Free Report)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.